Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2003
11/06/2003WO2003013549A3 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
11/06/2003WO2003009804A3 Conformationally constrained parathyroid hormone (pth) analogs
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002034204A3 Calcilytic compounds
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030207943 Administering dopamine, serotonin, and norepinephrine reuptake inhibitor (sibutramine) for treatment of neuropsychiatric disorders
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207879 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy
11/06/2003US20030207850 Hormone replacement therapy
11/06/2003US20030207846 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003CA2483701A1 Constitutively active histamine h3 receptor mutants and uses thereof
11/06/2003CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483005A1 Treatment of metabolic syndrome
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1359154A1 Further syntheses of cyproterone acetate
11/05/2003EP1358881A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
11/05/2003EP1357870A1 Bioadhesive cell foam film of sustained-release delivery
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP0839039B1 Paroxetine controlled release compositions
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454088A Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT)
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/05/2003CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone
11/05/2003CN1126566C Luteinizing hormone releasing hormone antagonist and use for medicine preparation for treating prostate hypertrophy and prostate cancer
11/04/2003US6642411 Compounds and compositions for delivering active agents
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003US6642212 Health supplement comprising naturally occurring phytoestrogen selected from any two or more of genistein, daidzein and/or their glycosides
11/04/2003US6642010 Identifying, monitoring, and treating women for breast precancer or cancer
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641840 Sustained release formulations for growth hormone secretagogues
10/2003
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089419A1 New 2-substituted -1,3-thiazole compounds
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002072106A3 Combined method for treating hormono-dependent disorders with exemestane
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002020090A9 Pharmaceutical compositions
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2480451A1 New 2-substituted -1,3-thiazole compounds
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355941A2 Long lasting growth hormone releasing factor derivatives
10/29/2003EP1355908A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
10/29/2003EP1355906A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355698A2 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1140047B1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
10/29/2003CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds
10/29/2003CN1452613A Amorphous torasemide modification
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638765 Platform for the differentiation of cells
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087196A1 Thermogelling oligopeptide polymers
10/23/2003WO2003087073A1 Estrogen receptor modulators
10/23/2003WO2003086464A1 Preventives/remedies for hotflash
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086388A1 Estrogen receptor modulators
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003053325A3 Microencapsulation of drugs by solvent exchange
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 290